to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
With immigrants in more than 40 percent of the cancer researcher slots at America’s top cancer institutes, these scientists are playing an integral role in improving cancer survival rates in the United States, according to a Kauffman Foundation-funded National Foundation for American Policy report released last month.
As a life science entrepreneur, you surely have ideas on how changing legal rules and policies could promote innovation and accelerate U.S. economic growth. The Kauffman Foundation, seeking suggestions on how to jumpstart the struggling economy, convened America’s leading legal scholars and social scientists to offer their thoughts.
With U.S. healthcare costs rising about 2.5 percent faster than inflation, there’s an urgent need to improve productivity and quality in American healthcare. A Kauffman Foundation report found that open access to medical data could help find that cost-benefit balance.
More than 6 percent of Inc. 500 firms work in the health and drug space, making it the No. 5 industrial sector for these fast-growing companies from 2005 to 2010. But these medical innovators aren’t all concentrated in the Silicon Valley.
A life science company's business model is important to its success. Read more about validating a business model.
Some entrepreneurial incubators are better than others. For a good role model, check out the University of Michigan.
Rick Wallace, recently appointed CEO of KLA-Tencor, shares his management philosophy and the key to the company's success over the last 30 years. He stresses the importance of having a clear vision, distinct values and a well defined strategy to take care of his key constituencies: employees, customers and shareholders.
Pfizer Inc. is testing a pilot of a virtual clinical trial program that could be of interest to medical device startups and young pharmaceutical and biotech companies.
Even with trained and certified internal quality-improvement leaders, or "belts," Six Sigma efforts can fail because management does not understand the support they need. Such ignorance can mean that Six Sigma quality projects don't match company strategy, receive the right resources or financial support, or benefit from regular reviews by managers who can resolve such issues. Entrepreneurs thinking about implementing a Lean Manufacturing-oriented process need to have a full appreciation not only for the returns but also for the investments required, especially their own time and energy and that of their top team".
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.